6ES5470-8MB12 440R-N23117
我司以停產(chǎn)控制系統(tǒng)零部件、為領(lǐng)先優(yōu)勢(shì)、我們有大量庫(kù)存和盈余操縱系統(tǒng)零件、停產(chǎn)的控制系統(tǒng)部分硬件、我們也發(fā)布了許多的硬件和產(chǎn)品來(lái)支持你現(xiàn)有的控制系統(tǒng)或運(yùn)用最新的控制技術(shù)、停產(chǎn)的“DCS系統(tǒng)備品 備件 PLC模塊 備件”整機(jī)及配件系列、有著強(qiáng)大的優(yōu)勢(shì)只要您需要的PLC產(chǎn)品、我們就能幫您找到。公司以“專(zhuān)業(yè)、 誠(chéng)信、創(chuàng)新、合作、共贏(yíng)”的經(jīng)營(yíng)理念、不斷開(kāi)發(fā)新產(chǎn)品、為客戶(hù)提供優(yōu)質(zhì)服務(wù)、以最大限度追求客戶(hù)滿(mǎn)意度、并不斷開(kāi)拓新領(lǐng)域業(yè)務(wù),充足庫(kù)存，交貨期快，
主營(yíng)產(chǎn)品:各品牌DCS、PLC備件---全新渠道,卓越品質(zhì),完美折扣!
一、英維思�？怂共_ Invensys Foxboro I/A Series系統(tǒng)：FBM（現(xiàn)場(chǎng)輸入/輸出模塊）順序控制、梯形邏輯控制、事故追憶處理、數(shù)模轉(zhuǎn)換、輸入/輸出信號(hào)處理、數(shù)據(jù)通信及處理等。
二、英維思ESD系統(tǒng) Invensys Triconex: 冗余容錯(cuò)控制系統(tǒng)、基于三重模件冗余（TMR）結(jié)構(gòu)的最現(xiàn)代化的容錯(cuò)控制器。
三、ABB：Bailey INFI 90，工業(yè)機(jī)器人備件DSQC系列等。
四、西屋Westinghouse： OVATION系統(tǒng)、WDPF系統(tǒng)、WEStation系統(tǒng)備件。
五、霍尼韋爾Honeywell：DCS系統(tǒng)備件模件、HONEYWELL TDC系列， QCS,S9000等備件。
六、安川Yaskawa：伺服控制器、伺服馬達(dá)、伺服驅(qū)動(dòng)器。
七、羅克韋爾Allen Bradley Rockwell: 1745/1756/ 1771/ 1785、Reliance瑞恩 等產(chǎn)品。
八、XYCOM：XVME-103、XVME-690、VME總線(xiàn)等備件
九、伍德沃德Woodward：SPC閥位控制器、PEAK150數(shù)字控制器。
十、施耐德Schneider：140系列、Quantum處理器、Quantum內(nèi)存卡、Quantum電源模塊等。
十一、摩托羅拉Motorola：MVME 162、MVME 167、MVME1772、MVME177、VME系列。
十二、發(fā)那科FANUC：模塊、卡件、驅(qū)動(dòng)器等各類(lèi)備件。
十三、西門(mén)子Siemens：Siemens MOORE， Siemens Simatic C1，Siemens數(shù)控系統(tǒng)等。
十四、博士力士樂(lè)Bosch Rexroth：Indramat，I/O模塊,PLC控制器,驅(qū)動(dòng)模塊等。
十五、HP:工作站、服務(wù)器、HP 9000 工作站、HP 75000 系列備件、HP VXI 測(cè)試設(shè)備等。
十六、尼康NOKI：輸入輸出卡件、模塊備件�；萜�
十七、MELEC: 驅(qū)動(dòng)器、驅(qū)動(dòng)板、伺服驅(qū)動(dòng)器、伺服控制器、馬達(dá),驅(qū)動(dòng)卡等。
十八、網(wǎng)域Network Appliance：數(shù)據(jù)儲(chǔ)存模塊。
In a study published in the US journal Science Translational Medicine, the researchers said they developed a smartphone app and used it to command engineered cells to produce insulin that helps diabetic mice achieve and maintain stable blood sugar levels within two hours.
"We believe that the ... concept could pave the way for a new era of personalized, digitalized, and globalized precision medicine," Haifeng Ye, professor of the East China Normal University in Shanghai, China, who led the study, told Xinhua.
For the study, the researchers first created cells that produced insulin when illuminated by far-red light, the same wavelengths emitted by therapy bulbs and infrared saunas.
Then, they added the cells to a soft bio-compatible sheath that also contained wirelessly-powered red LED lights to create HydrogeLEDs that could be turned on and off by an external command.
Finally, the HydrogeLEDs was implanted into the skin of diabetic mice to allow users to administer insulin doses remotely through a smart phone application.
In a small pilot experiment, the system also involved a control box called SmartController that communicates with the smart phone via the global GSM network and executes commands to turn on the HydrogeLEDs.
The scientists also paired the system with a Bluetooth-enabled glucometer, which allowed remote transmission of glycemic values to the smart phone for analysis.
When the measurements exceeded a pre-set threshold, the smartphone will signal the SmartController to turn on the HydrogeLEDs to enable insulin production.
"This work combines the unique capacity of electronic devices in reading and generating digital signals with the maximal theranostic precision of biological cells, and represents the first mobile healthcare system that unites the global markets of point-of-care technologies, mobile phone technology and cellular medicines," Ye said.
Ye expressed the hope that future versions of the system could have a glucometer, which would also be implanted in the body, to monitor the patients' blood sugar levels 24 hours a day in order to automatically trigger the therapeutic response.
Currently, more than 415 million people worldwide are living with diabetes, and frequently need to inject themselves with insulin to manage their blood sugars.
In a commentary accompanying the paper, Mark Gomelsky of the University of Wyoming said Ye's study takes us one step further toward "smart" cell-based therapies.
"How soon should we expect to see people on the street wearing fashionable LED wristbands that irradiate implanted cells engineered to produce genetically encoded drugs under the control of a smart phone?" asked Gomelsky. "Not just yet, but (this work) provides us with an exciting glimpse into the future of smart cell-based therapeutics."
（DCS系統(tǒng)）和（機(jī)器人系統(tǒng)）及（大型伺服控制系統(tǒng)）備件大賣(mài)！叫賣(mài)！特賣(mài)！賣(mài)賣(mài)賣(mài)！